Active ingredient
EVEROLIMUS
Registration activity, product holders, and manufacturers linked to this active ingredient in the AIPHARM dataset.
Registered products
8
Top manufacturer
Not available
Top holder
NOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
Updated
22 May 2026
Overview
Product registrations over time
Latest visible period: 2025
Analysis
Companies connected to this ingredient
Analysis
Product Manufacturer
| Manufacturer name | Product count |
|---|---|
| No data available | |
No data available
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 4 | |
| 4 |
Product count4
Product count4
Rows per page:
1–2 of 2
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| CERTICAN 0.25 MG TABLETS | MAL20071689ARZ | NEW CHEMICAL ENTITY | NOVARTIS CORPORATION (MALAYSIA) SDN. BHD. | NOVARTIS PHARMA STEIN AG | NOVARTIS CORPORATION (MALAYSIA) SDN. BHD. | PRODUCT APPROVED |
| CERTICAN 0.75 MG TABLETS | MAL20071691ARZ | NEW CHEMICAL ENTITY | NOVARTIS CORPORATION (MALAYSIA) SDN. BHD. | NOVARTIS PHARMA STEIN AG | NOVARTIS CORPORATION (MALAYSIA) SDN. BHD. | PRODUCT APPROVED |
| AFINITOR 5 MG TABLET | MAL20091942ARZ | NEW CHEMICAL ENTITY | NOVARTIS CORPORATION (MALAYSIA) SDN. BHD. | NOVARTIS PHARMA STEIN AG | NOVARTIS CORPORATION (MALAYSIA) SDN. BHD. | PRODUCT APPROVED |
| AFINITOR 10 MG TABLET | MAL20091943ARZ | NEW CHEMICAL ENTITY | NOVARTIS CORPORATION (MALAYSIA) SDN. BHD. | NOVARTIS PHARMA STEIN AG | NOVARTIS CORPORATION (MALAYSIA) SDN. BHD. | PRODUCT APPROVED |
| Evafin Everolimus Tablet 10 mg | MAL25076031AE | PRESCRIPTION | NOVUGEN ONCOLOGY SDN. BHD. | NOVUGEN ONCOLOGY SDN. BHD. | - | PRODUCT APPROVED |
| Evafin Everolimus Tablet 7.5 mg | MAL25076030AE | PRESCRIPTION | NOVUGEN ONCOLOGY SDN. BHD. | NOVUGEN ONCOLOGY SDN. BHD. | - | PRODUCT APPROVED |
| Evafin Everolimus Tablet 5 mg | MAL25076029AE | PRESCRIPTION | NOVUGEN ONCOLOGY SDN. BHD. | NOVUGEN ONCOLOGY SDN. BHD. | - | PRODUCT APPROVED |
| Evafin Everolimus Tablets 2.5 mg | MAL25076028AE | PRESCRIPTION | NOVUGEN ONCOLOGY SDN. BHD. | NOVUGEN ONCOLOGY SDN. BHD. | - | PRODUCT APPROVED |
CERTICAN 0.25 MG TABLETS
Product Reg. noMAL20071689ARZ
TypeNEW CHEMICAL ENTITY
Product HolderNOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
ManufacturerNOVARTIS PHARMA STEIN AG
ImporterNOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
Registration StatusPRODUCT APPROVED
CERTICAN 0.75 MG TABLETS
Product Reg. noMAL20071691ARZ
TypeNEW CHEMICAL ENTITY
Product HolderNOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
ManufacturerNOVARTIS PHARMA STEIN AG
ImporterNOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
Registration StatusPRODUCT APPROVED
AFINITOR 5 MG TABLET
Product Reg. noMAL20091942ARZ
TypeNEW CHEMICAL ENTITY
Product HolderNOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
ManufacturerNOVARTIS PHARMA STEIN AG
ImporterNOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
Registration StatusPRODUCT APPROVED
AFINITOR 10 MG TABLET
Product Reg. noMAL20091943ARZ
TypeNEW CHEMICAL ENTITY
Product HolderNOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
ManufacturerNOVARTIS PHARMA STEIN AG
ImporterNOVARTIS CORPORATION (MALAYSIA) SDN. BHD.
Registration StatusPRODUCT APPROVED
Evafin Everolimus Tablet 10 mg
Product Reg. noMAL25076031AE
TypePRESCRIPTION
Product HolderNOVUGEN ONCOLOGY SDN. BHD.
ManufacturerNOVUGEN ONCOLOGY SDN. BHD.
Importer-
Registration StatusPRODUCT APPROVED
Evafin Everolimus Tablet 7.5 mg
Product Reg. noMAL25076030AE
TypePRESCRIPTION
Product HolderNOVUGEN ONCOLOGY SDN. BHD.
ManufacturerNOVUGEN ONCOLOGY SDN. BHD.
Importer-
Registration StatusPRODUCT APPROVED
Evafin Everolimus Tablet 5 mg
Product Reg. noMAL25076029AE
TypePRESCRIPTION
Product HolderNOVUGEN ONCOLOGY SDN. BHD.
ManufacturerNOVUGEN ONCOLOGY SDN. BHD.
Importer-
Registration StatusPRODUCT APPROVED
Evafin Everolimus Tablets 2.5 mg
Product Reg. noMAL25076028AE
TypePRESCRIPTION
Product HolderNOVUGEN ONCOLOGY SDN. BHD.
ManufacturerNOVUGEN ONCOLOGY SDN. BHD.
Importer-
Registration StatusPRODUCT APPROVED
Rows per page:
1–8 of 8